Ronald E. Bruehlman - 08 Nov 2025 Form 4 Insider Report for GoodRx Holdings, Inc. (GDRX)

Role
Director
Signature
/s/ Gracye Cheng, Attorney-in-Fact for Ronald E Bruehlman
Issuer symbol
GDRX
Transactions as of
08 Nov 2025
Net transactions value
$0
Form type
4
Filing time
10 Nov 2025, 17:13:45 UTC
Previous filing
04 Jun 2025
Next filing
05 Jan 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Bruehlman Ronald E Director C/O GOODRX HOLDINGS, INC., 2701 OLYMPIC BOULEVARD, SANTA MONICA /s/ Gracye Cheng, Attorney-in-Fact for Ronald E Bruehlman 10 Nov 2025 0001604076

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GDRX Class A Common Stock Options Exercise +21,691 +24% 111,025 08 Nov 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GDRX Deferred Stock Unit Options Exercise $0 -21,691 -33% $0.000000 43,384 08 Nov 2025 Class A Common Stock 21,691 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The deferred stock unit award vested as to one-third of the shares underlying the award on November 8, 2025. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2029; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors).
F2 Each restricted stock unit represents a contingent right to receive one share of Class A common stock.